Bio-Based & Advanced Pharmaceutical Capsule Shells Market
完整報告名稱與涵蓋範圍
Bio-Based & Advanced Pharmaceutical Capsule Shells Market Size, Share & Trends Analysis Report, By Material (Hypromellose (HPMC) Capsules, Pullulan and Other Polysaccharide Capsules, Starch and Novel Bio-Based Polymer Capsules, Gelatin Capsules (Bovine, Porcine and Fish)), By Capsule Type (Hard Two-Piece Capsules, Softgel Capsules, Enteric, Delayed-Release and Functional Capsules), By Application (Pharmaceuticals, Nutraceuticals and Dietary Supplements, Clinical Trial and Dry Powder Inhalation Capsules), By End User, By Region, and Segment Forecasts, 2026-2035
報告摘要
The bio-based and advanced pharmaceutical capsule shells market covers empty hard capsules, softgels and functional capsule formats made from hypromellose, pullulan, starch and other non-animal polymers, together with gelatin capsules from bovine, porcine and fish sources, supplied to pharmaceutical, nutraceutical, clinical trial and inhalation applications. Filled finished products and capsule filling equipment are excluded.
The category is shifting toward plant-based and specialty polymers as manufacturers respond to vegetarian, halal and kosher preferences, cross-linking and moisture sensitivity issues with gelatin, and the needs of moisture-sensitive actives, probiotics and dry powder inhalers. Functional capsules with intrinsic enteric or delayed-release behaviour eliminate coating steps, transparent capsules support tamper-evident and clinical blinding requirements, and capsule manufacturers are investing in capacity, automated inspection and regulatory dossiers to serve drug applications rather than only supplements. Raw material price swings for gelatin and cellulose derivatives and rising quality expectations from regulators influence supplier selection.
Asia Pacific is the largest producing and consuming region led by India, China and South Korea, while North America and Europe drive premium plant-based and pharmaceutical-grade demand. Competition combines global capsule leaders, regional manufacturers scaling HPMC capacity and ingredient companies integrating into capsule production.
The InsightAce study delivers revenue forecasts in US$ across all material, capsule type, application and end user and regional segments for 2026-2035, alongside segment-level trend analysis, competitive landscape assessment and detailed company profiling.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Bio-Based & Advanced Pharmaceutical Capsule Shells Market Snapshot
Chapter 4. Global Bio-Based & Advanced Pharmaceutical Capsule Shells Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Material Estimates & Trend Analysis
5.1. Material & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Material:
5.2.1. Hypromellose (HPMC) Capsules
5.2.2. Pullulan and Other Polysaccharide Capsules
5.2.3. Starch and Novel Bio-Based Polymer Capsules
5.2.4. Gelatin Capsules (Bovine, Porcine and Fish)
Chapter 6. Market Segmentation 2: By Capsule Type Estimates & Trend Analysis
6.1. Capsule Type & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Capsule Type:
6.2.1. Hard Two-Piece Capsules
6.2.2. Softgel Capsules
6.2.3. Enteric, Delayed-Release and Functional Capsules
Chapter 7. Market Segmentation 3: By Application Estimates & Trend Analysis
7.1. Application & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Application:
7.2.1. Pharmaceuticals
7.2.2. Nutraceuticals and Dietary Supplements
7.2.3. Clinical Trial and Dry Powder Inhalation Capsules
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. End User & Market Share, 2026 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User:
8.2.1. Pharmaceutical Manufacturers
8.2.2. Nutraceutical Brands and Contract Packagers
8.2.3. CDMOs
Chapter 9. Bio-Based & Advanced Pharmaceutical Capsule Shells Market: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. South Korea
9.3.5. Australia
9.3.6. Southeast Asia
9.3.7. Rest of Asia Pacific
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Middle East & Africa
9.5.1. GCC Countries
9.5.2. South Africa
9.5.3. Rest of Middle East & Africa
Chapter 10. Competitive Landscape
10.1. Company Market Positioning Analysis
10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 11. Company Profiles
11.1. Lonza Group AG (Capsugel)
11.2. ACG Worldwide
11.3. Qualicaps (Roquette Freres)
11.4. Suheung Co., Ltd.
11.5. CapsCanada Corporation
11.6. Catalent (Novo Nordisk A/S)
11.7. Sunil Healthcare Limited
11.8. Natural Capsules Limited
11.9. Erawat Pharma Limited
11.10. Shanxi Guangsheng Medicinal Capsule Co., Ltd.
11.11. Zhejiang Yuexi Capsule Co., Ltd.
11.12. Bright Pharma Caps, Inc.
11.13. HealthCaps India Limited
11.14. Aenova Group
11.15. Farmacapsulas S.A.
圖表清單 List of Tables & Figures
Table 1. Global Bio-Based & Advanced Pharmaceutical Capsule Shells Market Revenue Forecast by Material, 2026-2035 (US$ Mn)
Figure 1. Global Bio-Based & Advanced Pharmaceutical Capsule Shells Market Segmentation Overview
Table 2. Global Bio-Based & Advanced Pharmaceutical Capsule Shells Market Revenue Forecast by Capsule Type, 2026-2035 (US$ Mn)
Figure 2. Global Bio-Based & Advanced Pharmaceutical Capsule Shells Market Share by Material, 2026 & 2035
Table 3. Global Bio-Based & Advanced Pharmaceutical Capsule Shells Market Revenue Forecast by Application, 2026-2035 (US$ Mn)
Figure 3. Capsule Material Mix Shift from Gelatin to Plant-Based Polymers, 2026-2035
Table 4. Global Bio-Based & Advanced Pharmaceutical Capsule Shells Market Revenue Forecast by End User, 2026-2035 (US$ Mn)
Figure 4. Global Bio-Based & Advanced Pharmaceutical Capsule Shells Market Share by Capsule Type, 2026 & 2035
Table 5. North America Bio-Based & Advanced Pharmaceutical Capsule Shells Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 5. Functional Capsule Innovation: Enteric, Delayed-Release, DPI and Moisture-Protective Formats
Table 6. Europe Bio-Based & Advanced Pharmaceutical Capsule Shells Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Asia Pacific Bio-Based & Advanced Pharmaceutical Capsule Shells Growth Opportunity Analysis
Table 7. Asia Pacific Bio-Based & Advanced Pharmaceutical Capsule Shells Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Global Capsule Manufacturing Capacity by Region and Material
Table 8. Latin America Bio-Based & Advanced Pharmaceutical Capsule Shells Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 8. Competitive Positioning of Key Bio-Based & Advanced Pharmaceutical Capsule Shells Market Participants
Table 9. Middle East & Africa Bio-Based & Advanced Pharmaceutical Capsule Shells Market Revenue by Country, 2026-2035 (US$ Mn)
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們